Eagle Pharmaceuticals
EGRX
#10434
Rank
A$7.34 M
Marketcap
A$0.57
Share price
0.00%
Change (1 day)
-46.30%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: A$7.34 Million

As of January 2026 Eagle Pharmaceuticals has a market cap of A$7.34 Million. This makes Eagle Pharmaceuticals the world's 10434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$7.34 M-15.59%
2025A$8.7 M-24.02%
2024A$11.45 M-88.51%
2023A$99.69 M-82.17%
2022A$0.55 B-38.36%
2021A$0.90 B14.93%
2020A$0.78 B-32.53%
2019A$1.16 B46.98%
2018A$0.79 B-22.06%
2017A$1.02 B-40.06%
2016A$1.70 B-10.5%
2015A$1.90 B615.91%
2014A$0.26 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
A$7.34 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$734.91 B 10,000,371.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$151.98 B 2,068,094.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
A$405.31 B 5,515,311.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
A$54.80 B 745,707.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
A$262.06 B 3,565,985.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.422 T 19,362,434.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$169.71 B 2,309,287.82%๐Ÿ‡บ๐Ÿ‡ธ USA